Clearwater Paper (CLW): Customer relationships after a transformational tissue divestiture
Clearwater Paper operates as a mid‑market manufacturer of private‑label bleached paperboard and tissue products, monetizing through direct sales of sheeted Solid Bleached Sulfate (SBS) paperboard to packaging converters and, until recently, a vertically integrated tissue business sold to a strategic buyer for cash. The company’s revenue model is concentrated, manufacturing‑led, and geography‑weighted toward North America, with sizable customer concentration among the top 10 buyers. For investors and operators, the recent tissue sale and follow‑on commercial arrangements materially reframe Clearwater Paper’s customer posture and cash dynamics. Visit the NullExposure homepage for deeper customer analytics: https://nullexposure.com/
The headline transaction: Sofidel takes the tissue business and changes the relationship map
Clearwater Paper completed the sale of its tissue business for US$1.06 billion in cash, transferring the consumer‑facing tissue operations to Sofidel’s U.S. arm while preserving some upstream pulp exposure. According to multiple March 2026 press reports, the buyer is Sofidel America Corp., a subsidiary of Italy‑based Sofidel S.p.A., and the transaction closed for $1.06 billion before customary adjustments (StockTitan and Tissue Online North America, March 2026). The sale monetized a non‑core asset and increased Clearwater’s liquidity while converting a direct retail channel into a supplier/customer relationship on specific inputs such as pulp.
Customer roster and what each relationship means for CLW
Sofidel America Corp. / Sofidel America Corporation
Clearwater Paper sold its tissue business to Sofidel’s U.S. subsidiary for US$1.06 billion in cash, effectively removing Clearwater as the operator of that retail tissue franchise and shifting a large line of business to Sofidel’s platform (StockTitan, March 2026; Big Country News Connection, March 2026). Several coverage items document the definitive agreement and closing in March 2026.
Sofidel S.p.A.
Sofidel S.p.A., the Italian parent of the U.S. buyer, is the strategic owner now controlling the acquired tissue assets and supply chain, giving Clearwater a major counterparty relationship through purchase and transition arrangements tied to the sale (StockTitan, March 2026). Coverage identifies Sofidel’s global platform as the acquirer behind the U.S. deal.
MM Packaging Puerto Rico
MM Packaging Puerto Rico is identified in regional reporting as the subject of a commercial dispute over exclusive representation rights for SBS paperboard sales, with an article describing litigation dynamics and Clearwater’s contractual posture in FY2025 (NewsIsMyBusiness, March 2026). The item signals a contentious commercial relationship around representation and sales channels in Puerto Rico’s pharma and consumer packaging markets.
Fred Meyer
Historical trade coverage indicates Clearwater’s tissue products were carried in retailers such as Fred Meyer under private‑label arrangements, illustrating how retail grocery partners served as distribution points for the company’s consumer tissue lines prior to the Sofidel sale (Spokane Journal, cited 2013 reporting referenced in March 2026 aggregation). This relationship is representative of Clearwater’s prior indirect retail exposure.
Safeway
Safeway also appears in historical retail placement reporting for Clearwater’s private‑label tissue products, showing that major grocery chains functioned as downstream distribution endpoints for Clearwater’s consumer tissue portfolio before the business was divested (Spokane Journal, historical reporting referenced in March 2026).
Albertsons
Albertsons is referenced alongside other grocery chains as a retail outlet for Clearwater’s private‑label tissue, again underscoring the former direct channel relationships that were part of the divested tissue business (Spokane Journal, historical reporting aggregated in March 2026).
What the relationships collectively reveal about Clearwater’s operating model
- Contracting posture: short‑term transition and service arrangements. Company disclosures indicate Clearwater is operating under a Transition Services Agreement with the buyer to provide back‑office accounting and IT support through October 31, 2025, signaling short‑term, time‑boxed post‑close obligations rather than long‑duration integrated contracts.
- Geographic concentration: North America first, limited global reach. Net sales by geography show the United States dominates revenue, and the company emphasizes serving North American packaging converters—consistent with two high‑confidence geography signals indicating North America as primary and a secondary global presence from limited foreign shipments.
- Customer concentration is material. Clearwater reports its top 10 paperboard customers accounted for 45% of sales in 2024, which creates revenue concentration risk and bargaining leverage concerns in negotiations with large converters.
- Relationship role and criticality: seller to packaging converters. Clearwater sells sheeted paperboard directly to folding carton converters, merchants, and printers; the business is manufacturing‑centric and critical to its converter customers’ supply chains.
- Segment maturity and strategic reset. The $1.06 billion divestiture shifts Clearwater away from consumer retailing into a more focused industrial paperboard manufacturer profile, improving balance sheet flexibility but concentrating exposure to cyclical packaging demand.
These operating signals combine into a clear profile: a capital‑intensive manufacturer with high customer concentration and near‑term contractual wrap‑ups tied to a major divestiture—an outlook that changes capital allocation priorities and counterparty risk management.
For a deeper look at how these customer relationships map to supplier concentration and counterparty risk, explore full customer intelligence on the NullExposure homepage: https://nullexposure.com/
Implications for investors and operators
- Balance sheet and liquidity: The Sofidel sale delivers significant cash proceeds, reducing leverage risk and enabling strategic reinvestment into paperboard operations or debt paydown. Public filings and news reports from March 2026 confirm the $1.06 billion figure.
- Revenue profile shift: Removing the consumer tissue business reweights Clearwater’s revenue toward B2B packaging sales, increasing dependence on a smaller number of large converter customers (top‑10 = 45% of sales).
- Commercial friction and legal risk: The MM Packaging Puerto Rico dispute illustrates active contract enforcement and potential revenue disruption in specific markets; this is a working commercial risk to monitor in FY2025 coverage.
- Operational handoffs: The short‑term Transition Services Agreement creates a defined timeline for Clearwater to extract value from the divested business while supporting the buyer through transition; investors should track the completion of services and any contingent purchase price adjustments.
Learn how to translate these customer signals into investment‑grade insights at NullExposure: https://nullexposure.com/
Bottom line and next steps for analysis
Clearwater Paper has recast itself into a focused paperboard manufacturer with improved liquidity but greater concentration risk among large converter customers. The Sofidel transaction and associated agreements are the dominant customer‑relationship events for the company in early 2026; operational execution on the transition services and commercial terms with remaining top customers will determine whether the company converts the sale proceeds into sustainable margin improvement or faces renewed cyclicality.
For actionable tracking and deeper customer relationship scoring tailored to investors and operators, visit NullExposure and request a walkthrough of our CLW coverage: https://nullexposure.com/